Derivative exercise or conversion — not an open-market buy.
Traded Feb 27, 2026 · Filed Mar 3, 2026
Charles Schwab Corporation's MD, Head of Advisor Services sold $193K of Charles Schwab Corporation shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$193,454
Shares × reported transaction price
37 days after results of Jan 21, 2026, 48 days before results of Apr 16, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $95.20 on Feb 27, 2026, 38% above its 52-week low and 11% below its high, after a 7% drop over the previous 30 trading days
52-week range $69.06 (Apr 4, 2025) to $107.21 (Feb 9, 2026), 69% of the way up, from 251 adjusted closes. 30 trading days earlier: $101.92 on Jan 14, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Oct 6, 2025 in the U.S. District Court, E.D. Texas. A filing is an allegation, not a finding.
2 such cases were open. Lewis v. Charles Schwab & Co., Inc., docket 4:25-cv-01086, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -3.5% | -1.3% | -2.2% |
| 30 days | -3.2% | -3.8% | +0.6% |
| 90 days | -8.8% | +10.9% | -19.6% |
| 180 days | +14.3% | +12.0% | +2.4% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.